Most Recent
Industry standards group Meat & Livestock Australia can bring a cross-claim for indemnity against the Agricultural Business Research Institute while defending a case alleging it infringed a patent for inferring bovine gene traits.
An appeals court has found that a judge misapprehended the Evidence Act by saying the legal team in a dispute over $100 million in land may be complicit in obtaining evidence unlawfully, and that there was no need for the lawyers to withdraw from the case.
Construction PRO
An appeals court has found that a judge misapprehended the Evidence Act by saying the legal team in a dispute over $100 million in land may be complicit in obtaining evidence unlawfully, and that there was no need for the lawyers to withdraw from the case.
"Quite unsatisfactory", is how a judge has described a revived intellectual property dispute between German drug maker Merck KGaA and US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia.
A company owned by ex-Goldstone Private Equity managing director Alexandra Commins can't assert privilege over Thomson Geer advice that was provided jointly to her business partner James Angelis, ahead of a hearing on penalty after the court found the PE firm acted oppressively towards her.
Gaming company Light & Wonder has been hit with a securities class action over disclosures about its Dragon Train poker game, after an employee's theft of rival Aristocrat's trade secrets led to litigation that settled for $190 million.
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off.
Gaming company Light & Wonder will pay $190 million to settle Aristocrat’s litigation in Australia and the United States alleging it misappropriated trade secrets in developing two poker machines.
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.
A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.